- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q2 2025 · Mar 31, 2025 | $12M |
| Long Term Debt | Q2 2025 · Sep 30, 2024 | $0 |
| Short Term Debt | Q2 2025 · Mar 31, 2025 | $0 |
| Short Term Debt | Q2 2025 · Sep 30, 2024 | $26.22M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $7.75M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $86.54M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $385.17M |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $379.74M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $67.69M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $164.73M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $132.7M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $215.32M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $80M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $153.39M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $646.36M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $730.68M |
| Total Assets restated | Q2 2025 · Mar 31, 2024 | $625.84M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 23.72M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 23.73M sh |
| Stock Repurchased | Q2 2025 · Mar 31, 2024 | $0 |
| Capex | Q2 2025 · Mar 31, 2024 | $1.54M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $25.15M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.08 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.13 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.08 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.13 |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $27.43M |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $54.61M |
| Net Income | Q2 2025 · Mar 31, 2024 | $1.88M |
| Net Income | Q2 2025 · Mar 31, 2024 | $2.98M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | $2.49M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | $3.97M |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $57.97M |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $113.02M |